SUMATRIPTAN (SUMATRIPTAN) — FDA Approval ANDA208967 (REGCON HOLDINGS)
SUMATRIPTAN (SUMATRIPTAN) — FDA Approval ANDA208967 (REGCON HOLDINGS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SUMATRIPTAN; Active ingredients: SUMATRIPTAN; Application number: ANDA208967.
| Brand name | SUMATRIPTAN |
|---|---|
| Active ingredients | SUMATRIPTAN |
| Application number | ANDA208967 |
| Sponsor | REGCON HOLDINGS |
| Dosage form | SPRAY |
| Route | NASAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20210217 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →